Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fantini

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|January 15, 1990
Effect of VIP on the glycogen metabolism of human colon adenocarcinoma cells studied by 13C nuclear magnetic resonance spectroscopyJ P Galons, J Fantini, J Vion-Dury, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1993
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptorJ Fantini, D G Cook, N Nathanson, et al.
Journal of Cellular Physiology|June 1, 1990
Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell lineJ M Culouscou, M Remacle-Bonnet, F Garrouste, et al.
Journal of Cellular Physiology|October 1, 1989
Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cellsJ Fantini, J B Rognoni, J M Culouscou, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1993
Multi-branched peptides based on the HIV-1 V3 loop consensus motif inhibit HIV-1 and HIV-2 infection in CD4+ and CD4- cellsJ Fantini, N Yahi, K Mabrouk, et al.
The Journal of Biological Chemistry|September 30, 1994
Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cellsN Yahi, J M Sabatier, P Nickel, et al.
Experimental Cell Research|July 1, 1990
Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free mediumJ Fantini, B Verrier, C Robert, et al.
European Journal of Cell Biology|June 1, 1987
Evidence for an ectophosvitin kinase activity that phosphorylates a 123 kDa endogenous substrate on a human colonic adenocarcinoma cell (HT 29)J Fantini, J M Muller, B Abadie, et al.
In Vitro Cellular & Developmental Biology. Animal|June 1, 1995
SPC3, a nontoxic peptide inhibitor of HIV infectionJ M Sabatier, S Baghdiguian, N Yahi, et al.
AIDS (London, England)|September 26, 1997
Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29O Delézay, N Koch, N Yahi, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|January 15, 1990
Effect of VIP on the glycogen metabolism of human colon adenocarcinoma cells studied by 13C nuclear magnetic resonance spectroscopyJ P Galons, J Fantini, J Vion-Dury, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1993
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptorJ Fantini, D G Cook, N Nathanson, et al.
Journal of Cellular Physiology|June 1, 1990
Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell lineJ M Culouscou, M Remacle-Bonnet, F Garrouste, et al.
Journal of Cellular Physiology|October 1, 1989
Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cellsJ Fantini, J B Rognoni, J M Culouscou, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1993
Multi-branched peptides based on the HIV-1 V3 loop consensus motif inhibit HIV-1 and HIV-2 infection in CD4+ and CD4- cellsJ Fantini, N Yahi, K Mabrouk, et al.
The Journal of Biological Chemistry|September 30, 1994
Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cellsN Yahi, J M Sabatier, P Nickel, et al.
Experimental Cell Research|July 1, 1990
Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free mediumJ Fantini, B Verrier, C Robert, et al.
European Journal of Cell Biology|June 1, 1987
Evidence for an ectophosvitin kinase activity that phosphorylates a 123 kDa endogenous substrate on a human colonic adenocarcinoma cell (HT 29)J Fantini, J M Muller, B Abadie, et al.
In Vitro Cellular & Developmental Biology. Animal|June 1, 1995
SPC3, a nontoxic peptide inhibitor of HIV infectionJ M Sabatier, S Baghdiguian, N Yahi, et al.
AIDS (London, England)|September 26, 1997
Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29O Delézay, N Koch, N Yahi, et al.
Pageof 11